Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 7.22 is 70% above its 5-year average of 4.25, around the middle of its 5-year range (0.58–14.82).
As of the fiscal period ended Tuesday, June 30, 2026. 30.89% above its 12-month average of 5.52.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.22.
QUICK RATIO (ACID-TEST)
7.22
QUICK RATIO (ACID-TEST) AVG TTM
5.52
QUICK RATIO (ACID-TEST) AVG 3Y
3.13
QUICK RATIO (ACID-TEST) AVG 5Y
4.25
QUICK RATIO (ACID-TEST) AVG 10Y
4.84
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+30.89%
CURRENT VS 3Y AVG
+130.42%
CURRENT VS 5Y AVG
+70.09%
CURRENT VS 10Y AVG
+49.07%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.15
median of 685 covered companies
CURRENT VS SECTOR MEDIAN
+129.24%
vs the sector median at left
Bio Green Med Solution, Inc.
Market Cap
$4.69M
Quick Ratio (Acid-Test)
7.22
TTM Avg
5.52
3Y Avg
3.13
5Y Avg
4.25
Market Cap
$4.83M
Quick Ratio (Acid-Test)
10.60
TTM Avg
4.75
3Y Avg
13.37
5Y Avg
23.75
Market Cap
$4.55M
Quick Ratio (Acid-Test)
2.73
TTM Avg
3.29
3Y Avg
4.75
5Y Avg
4.47
Market Cap
$4.94M
Quick Ratio (Acid-Test)
5.58
TTM Avg
4.46
3Y Avg
3.04
5Y Avg
7.15
Market Cap
$4.40M
Quick Ratio (Acid-Test)
40.30
TTM Avg
26.48
3Y Avg
43.98
5Y Avg
50.08
Market Cap
$5.01M
Quick Ratio (Acid-Test)
1.84
TTM Avg
1.72
3Y Avg
1.97
5Y Avg
1.97
Market Cap
$4.33M
Quick Ratio (Acid-Test)
1.35
TTM Avg
3.30
3Y Avg
6.18
5Y Avg
6.77
Market Cap
$4.20M
Quick Ratio (Acid-Test)
1.95
TTM Avg
2.83
3Y Avg
3.75
5Y Avg
3.40
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio Green Med Solution, Inc. (BGMS) | $4.69M | 7.22 | 5.52 | 3.13 | 4.25 |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.83M | 10.60 | 4.75 | 13.37 | 23.75 |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | 2.73 | 3.29 | 4.75 | 4.47 |
| CalciMedica, Inc. (CALC)vs › | $4.94M | 5.58 | 4.46 | 3.04 | 7.15 |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.40M | 40.30 | 26.48 | 43.98 | 50.08 |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.01M | 1.84 | 1.72 | 1.97 | 1.97 |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.33M | 1.35 | 3.30 | 6.18 | 6.77 |
| Imunon, Inc. (IMNN)vs › | $5.08M | 1.82 | 1.99 | 2.53 | 3.43 |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.20M | 1.95 | 2.83 | 3.75 | 3.40 |
| Lunai Bioworks Inc. (LNAI)vs › | $5.19M | 0.19 | 0.06 | 0.46 | 2.58 |
Quick Ratio
7.22
Excludes inventory
Current Ratio
8.63
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 7.22 |
| 2026-03-31 | 5.87 |
| 2025-12-31 | 3.66 |
| 2025-09-30 | 5.07 |
| 2025-06-30 | 5.77 |
| 2025-03-31 | 5.60 |
| 2024-12-31 | 0.59 |
| 2024-09-30 | 0.77 |
| 2024-06-30 | 1.07 |
| 2024-03-31 | 0.58 |
| 2023-12-31 | 0.91 |
| 2023-09-30 | 1.36 |
| 2023-06-30 | 2.27 |
| 2023-03-31 | 2.59 |
| 2022-12-31 | 3.25 |
| 2022-09-30 | 6.41 |
| 2022-06-30 | 6.38 |
| 2022-03-31 | 5.90 |
| 2021-12-31 | 7.56 |
| 2021-09-30 | 12.08 |
| 2021-06-30 | 14.82 |
| 2021-03-31 | 18.20 |
| 2020-12-31 | 14.27 |
| 2020-09-30 | 15.15 |
| 2020-06-30 | 18.47 |
| 2020-03-31 | 7.76 |
| 2019-12-31 | 5.79 |
| 2019-09-30 | 7.65 |
| 2019-06-30 | 7.26 |
| 2019-03-31 | 8.09 |
| 2018-12-31 | 4.45 |
| 2018-09-30 | 5.16 |
| 2018-06-30 | 5.68 |
| 2018-03-31 | 5.81 |
| 2017-12-31 | 6.32 |
| 2017-09-30 | 6.52 |
| 2017-06-30 | 3.72 |
| 2017-03-31 | 4.13 |
| 2016-12-31 | 3.73 |
| 2016-09-30 | 4.05 |
| 2016-06-30 | 3.37 |
| 2016-03-31 | 3.95 |
| 2015-12-31 | 4.27 |
| 2015-09-30 | 5.09 |
| 2015-06-30 | 4.70 |
| 2015-03-31 | 4.30 |
| 2014-12-31 | 3.87 |
